美股市场个股详情
ACER ACER THERAPEUTICS INC
- 0.660
- 0.0000.00%
延时15分钟行情收盘价 08/13 16:00 (美东)
1614.85万总市值-0.34市盈率TTM
0.000最高价0.000最低价0股成交量0.000今开0.660昨收0.00成交额0.00%换手率亏损市盈率(静)2446.37万总股本0.66052周最高-0.49市净率1248.83万流通值0.66052周最低--股息TTM1891.87万流通股0.660历史最高--股息率TTM0.00%振幅0.660历史最低--平均价1股每手
关于ACER THERAPEUTICS INC公司
Acer Therapeutics Inc是一家制药公司。 原则上，它专注于针对严重的稀有和超稀有疾病以及关键的未满足医疗需求的患者的疗法的获取，开发和商业化。 该公司的临床项目包括三类严重的遗传疾病，即针对vEDS的EDSIVO和针对尿素循环疾病和枫糖浆尿病的ACER-001。
公司介绍
董事高管
- 姓名
- 职务
- 年薪
- Chris Schelling
- Director, President and Chief Executive Officer
- 83.43万
- Dr. Adrian Quartel
- Chief Medical Officer
- 80.10万
- Tanya Hayden
- Chief Operating Officer
- --
- John M. Klopp
- Chief Technical Officer
- --
- Jefferson E. Davis
- Chief Business Officer
- --
- Bernie Paul
- Chief People Officer
- --
- Donald R. Joseph
- Chief Legal Officer and Secretary
- --
- Harry S. Palmin
- Principal Accounting Officer and Chief Financial Officer
- 59.26万
- Stephen J. Aselage
- Chairman of the Board
- 10.50万
- Jason Amello
- Independent Director
- 8.31万
- Michelle R. Griffin
- Independent Director
- 8.81万
- John M. Dunn
- Independent Director
- 8.50万
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据